Prognostic factors for patients with gastric cancer after surgical resection

Reports of Practical Oncology and Radiotherapy

Volumn 11, Issue 5, 2006, Pages 235-246

  Kycler, Witold ^a   Teresiak, Marek ^a   Łoziński, Cezary ^a  

^a Great Poland Cancer Centre   (Poland)

Author keywords

Gastric cancer; Prognostic factors; Statistics; Surgical treatment

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; STOMACH CANCER; SURVIVAL TIME; TOTAL STOMACH RESECTION; TUMOR VOLUME; WEIGHT REDUCTION;

EID: 33845954954     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1507-1367(06)71069-0     Document Type: Article

References (44)

1. Didkowska J, Wojciechowska U, Tarkowski W, Zatoński W: Nowotwory złośliwe w Polsce w 1999 roku. Centrum Onkologii - Instytut Marii Skłodowskiej Curie 2002
2. Wayman J, Forman D, Griffin SM: Monitoring the changing pattern of esophago-gastric cancer: data from a UK regional cancer registry. Cancer Causes Control, 2001; 12: 943-9
3. Terry MB, Gaudet MM, Gammon MD: The epidemiology of gastric cancer. Semin Radiat Oncol, 2002; 12: 111-27
4. Kranenbarg EK, van de Velde CJ: Gastric cancer in the eldery. Eur J Surg Oncol, 1998; 24: 384-90
5. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr: Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA, 1991; 265: 1287-9
6. de Manzoni G, Pedrazzani C, Di Leo A et al: Metastases to the para-aortic lymph nodes in adenocarcinoma of the cardia. Eur J Surg, 2001; 167: 413-8
7. Siewert JR, Stein HJ: Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg, 1998; 85: 1457-9
8. Driessen A, Van Raemdonck D, De Leyn P et al: Are carcinomas of the cardia oesophageal or gastric adenocarcinomas? Eur J Cancer, 2003; 39: 2487-94
9. th ed. New York: WB Saunders, 2001
10. th ed. New York: Springer-Verlag, 2002
11. Dhar DK, Kubota H, Kinukawa N, Maruyama R et al: Prognostic significance of metastatic lymph node size in patients with gastric cancer. Br J Surg, 2003; 90: 1522-30
12. Bonenkamp JJ, Songun I, Hermans J et al: Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet, 1995; 345: 745-8
13. McCulloch P, Niita ME, Kazi H et al: Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg, 2005; 92: 5-13
14. Hartgrink HH, van de Velde CJH, Putter H et al: Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch Gastric Cancer Study Group Trial. J Clin Oncol, 2004; 22: 2069-77
15. Degiuli M, Sasako M, Ponti A et al: Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study. J Clin Oncol, 1998; 16: 1490-3
16. Cuschieri A, Fayers P, Fielding J et al: Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet, 1996; 347: 995-9
17. Robertson CS, Chung SCS, Woods SDS et al: A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg, 1994; 220: 175-82
18. Bonenkamp JJ, Songun I, Hermans J et al: Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet, 1995; 345: 745-8
19. Kooby DA, Surawinata A, Klimstra DS et al: Biologic predictors of survival in node-negative gastric cancer. Ann Surg, 2003; 237: 828-37
20. National Cancer Institute. Surveillance, epidemiology, and results: incidence, stomach cancer. Available at: http://www.seer.cancer.gov/ faststats/html/inc_stomach.html 2004
21. Borie F, Rigau V, Fingerhut A, Millat B: Prognostic Factors for Early Gastric Cancer in France: Cox Regression Analysis of 322 Cases. World J Surg, 2004; 28: 686-91
22. Guadagni S, Reed PI, Johnston BJ et al: Early gastric cancer: follow-up after gastrectomy in 159 patients. Br J Surg, 1993; 80: 325-8
23. Coleman MP, Esteve J, Damiecki P et al: Trends in cancer incidence and mortality. IARC Sci Publ, 1993; 1-806
24. Faivre J, Forman D, Esteve J, Gatta G: Survival of patients with oesophageal and gastric cancers in Europe. Eur J Cancer, 1998; 34: 2167-75
25. Bonenkamp JJ, Hermans J, Sasako M et al: Extended lymphnode dissection for gastric cancer. Dutch Gastric Cancer group. N Engl J Med, 1999; 340: 908-14
26. Hohenberger P, Gretschel S: Gastric cancer. Lancet, 2003; 362: 305-15
27. Ranaldi R, Santinelli A, Verdolini R et al: Long term follow-up in early gastric cancer: evaluation of prognostic factors. J Pathol, 1995; 177: 343-51
28. Kim JP, Hur YS, Yang HK: Lymph node metastasis as a significant prognostic factor in early gastric cancer: analysis of 1136 early gastric cancers. Ann Surg Oncol, 1995; 2: 308-13
29. Behrns KE, Dalton RR, Van Heerden JA et al: Extended lymph node dissection for gastric cancer: is it value? Surg Clin North Am, 1992; 72: 433-43
30. Komatsu S, Ichikawa D, Kurioka H et al: Prognostic and clinical evaluation of patients with T2 gastric cancer. Hepatogastroenterology, 2005; 52: 965-8
31. Kunisaki C, Shimada H, Nomura M et al: Surgical outcome in patients with gastric adenocarcinoma in the upper third of the stomach. Surgery, 2005; 137: 165-71
32. de Manzoni G, Pedrazzani C, Pasini F et al: Results of surgical treatment of adenocarcinoma of the gastric cardia. Ann Thorac Surg, 2002; 73: 1035-40
33. Katai H, Sano T, Fukagawa T et al: Prospective study of proximal gastrectomy for early gastric cancer in the upper third od the stomach. Br J Surg, 2003; 90: 850-3
34. Hohenberger P, Gretschel S: Gastric cancer. Lancet, 2003; 362: 5-15
35. Meyer C, Lozac'h P, Rohr S et al: Gastric cancer: the French survey. Acta Gastroenterol Belg, 2002; 65: 161-5
36. Faycal J, Bessaguet C, Nousbaum JB et al: Epidemiology and long term survival of gastric carcinoma in the French district of Finistere between 1984 and 1995. Gastroenterol Clin Biol, 2005; 29: 23-32
37. Wayman J, Hayes N, Raimes SA, Griffin MS: Prescription of proton pump inhibitors before endoscopy. A potential cause of missed diagnosis of early gastric cancer. Arch Fam Med, 2000; 9: 385-88
38. Maehara Y, Okuyama T, Oshiro T et al: Early carcinoma of the stomach. Surg Gynecol Obstet, 1993; 177: 593-7
39. Nakamura T, Yao T, Niho Y, Tsuneyoshi M: A clinicopathological study in young patients. J Am Coll Surg, 1999; 188: 22-6
40. Kim DY, Kyoon J, Ryu SY et al: Clinicopathologic characteristic of gastric carcinoma in eldery patients: A comparison with young patients. World J Gastroenterol, 2005; 11: 22-6
41. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at histo-clinical classification. Acta Pathol Microbiol Scand, 1965; 64: 31-49
42. Shah MA, Schwartz GK: Treatment of metastatic esophagus and gastric cancer. Semin Oncol, 2004; 31: 574-87
43. Schwartz RE: Postoperative adjuwant chemoradiation therapy for patients with resected gastric cancer: intergroup 116. J Clin Oncol, 2001; 19: 1879-80
44. Sasako M: Clinical trials of surgical treatment of malignant diseases. Int J Clin Oncol, 2005; 10: 165-70